Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Roivant Sciences Ltd. Director's Dealing 2019

Mar 19, 2019

30587_dirs_2019-03-19_20b583c9-239e-472d-9e58-263020dd9309.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axovant Sciences Ltd. (AXON)
CIK: 0001636050
Period of Report: 2019-03-18

Reporting Person: Roivant Sciences Ltd. (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-03-18 Common Shares, par value $0.00001 per share P 6666667 $1.50 Acquired 105952381 Direct